---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-008918"
form_type: "8-K"
ticker: "IMCR"
cik: "0001671927"
company_name: "Immunocore Holdings plc"
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:50:08.679953+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Immunocore registers up to $150M of 2.50% convertible notes for resale by selling holders

## Summary
- Filed prospectus supplement on March 17, 2025 covering resale of up to $150M aggregate principal of 2.50% Convertible Senior Notes due 2030.
- Entered first supplemental indenture to add Trust Indenture Act provisions; legal opinions from Cooley (UK) LLP and Cooley LLP attached.
- Selling securityholders may also resell ADSs and ordinary shares issuable upon conversion of the notes.

## SEC filing metadata
- accession: 0001140361-25-008918
- form_type: 8-K
- ticker: IMCR
- cik: 0001671927
- company_name: Immunocore Holdings plc
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671927/000114036125008918/0001140361-25-008918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671927/000114036125008918/ny20045585x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-008918
- JSON: https://secwatch.observer/filing/0001140361-25-008918.json
- Plain text: https://secwatch.observer/filing/0001140361-25-008918.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.